Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia M Ferrari

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|May 14, 2014
Thyroid dysfunctions induced by tyrosine kinase inhibitorsPoupak Fallahi, Silvia M Ferrari, Roberto Vita, et al.
Recent Patents on Anti-Cancer Drug Discovery|July 9, 2015
Cabozantinib in Thyroid CancerPoupak Fallahi, Silvia M Ferrari, Flavia Di Bari, et al.
Current Genomics|June 2, 2012
New targeted therapies for thyroid cancerAlessandro Antonelli, Poupak Fallahi, Silvia M Ferrari, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently AppliedSilvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Minerva Endocrinologica|June 27, 2015
Aggressive thyroid cancer: targeted therapy with sorafenibAlda Corrado, Silvia M Ferrari, Ugo Politti, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|May 14, 2014
Thyroid dysfunctions induced by tyrosine kinase inhibitorsPoupak Fallahi, Silvia M Ferrari, Roberto Vita, et al.
Recent Patents on Anti-Cancer Drug Discovery|July 9, 2015
Cabozantinib in Thyroid CancerPoupak Fallahi, Silvia M Ferrari, Flavia Di Bari, et al.
Current Genomics|June 2, 2012
New targeted therapies for thyroid cancerAlessandro Antonelli, Poupak Fallahi, Silvia M Ferrari, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently AppliedSilvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Minerva Endocrinologica|June 27, 2015
Aggressive thyroid cancer: targeted therapy with sorafenibAlda Corrado, Silvia M Ferrari, Ugo Politti, et al.
Pageof 1